SYRE vs GBCI

Comparison between Spyre Therapeutics Inc (SYRE, Company) and Glacier Bancorp Inc (GBCI, Company).

SYRE is from the Healthcare sector, while GBCI is from the Financial Services sector.

5-Year PerformanceGBCI has outperformed SYRE, delivering a return of -1.9% compared to -17.6%

SYRE vs GBCI - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	SYRE(COMPANY)	GBCI(COMPANY)
Market Cap	$6.02B	$6B
Max Drawdown	99.11%	66.75%
Sharpe Ratio	2.61	0.37
5Y Beta	1.73	1.11
Industry	Biotechnology	Banks - Regional
P/E Ratio	-30.92	21.55
Forward P/E	N/A	21.37
PEG Ratio	N/A	1.49
Dividend Yield	N/A	2.84%
5Y Dividends CAGR	N/A	9.67%
5Y EPS CAGR	-2.15%	-7.64%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	-3.09%	6.25%
P/S Ratio	650.22	5.79
P/B Ratio	12.65	1.50

Market Cap

Winner

SYRE

$6.02B

GBCI

$6B

Max Drawdown

SYRE

99.11%

Winner

GBCI

66.75%

Sharpe Ratio

Winner

SYRE

2.61

GBCI

0.37

5Y Beta

SYRE

1.73

Winner

GBCI

1.11

Industry

SYRE

Biotechnology

GBCI

Banks - Regional

P/E Ratio

Winner

SYRE

-30.92

GBCI

21.55

Forward P/E

SYRE

N/A

GBCI

21.37

PEG Ratio

SYRE

N/A

GBCI

1.49

Dividend Yield

SYRE

N/A

GBCI

2.84%

5Y Dividends CAGR

SYRE

N/A

GBCI

9.67%

5Y EPS CAGR

Winner

SYRE

-2.15%

GBCI

-7.64%

Debt to Equity

SYRE

0.00%

GBCI

0.00%

Free Cash Flow Yield

SYRE

-3.09%

Winner

GBCI

6.25%

P/S Ratio

SYRE

650.22

Winner

GBCI

5.79

P/B Ratio

SYRE

12.65

Winner

GBCI

1.50

SYRE vs GBCI - Historical Returns

Returns include dividend reinvestment.

Period	SYRE	GBCI
1 month	-4.01%	-4.39%
3 months	+91.48%	-6.29%
6 months	+190.79%	+17.99%
1 year	+370.97%	+13.28%
5 years(CAGR)	-17.65%	-1.85%
10 years(CAGR)	-9.26%	+9.39%
Max(CAGR)	-11.62%	+10.82%

Winner

SYRE

-4.01%

GBCI

-4.39%

Winner

SYRE

+91.48%

GBCI

-6.29%

Winner

SYRE

+190.79%

GBCI

+17.99%

Winner

SYRE

+370.97%

GBCI

+13.28%

5Y(CAGR)

SYRE

-17.65%

Winner

GBCI

-1.85%

10Y(CAGR)

SYRE

-9.26%

Winner

GBCI

+9.39%

Max(CAGR)

SYRE

-11.62%

Winner

GBCI

+10.82%

SYRE vs GBCI - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	SYRE	GBCI
2026	+129.17%	+5.57%
2025	+37.36%	-8.55%
2024	+8.79%	+23.62%
2023	+104.27%	-12.49%
2022	-90.57%	-11.34%
2021	-44.51%	+27.49%
2020	+1.55%	+4.17%
2019	-4.98%	+18.98%
2018	+39.22%	+4.10%
2017	+18.38%	+12.78%
2016	-55.48%	+46.87%
2015	N/A	+0.43%
2014	N/A	-3.43%
2013	N/A	+101.19%
2012	N/A	+23.86%
2011	N/A	-19.37%
2010	N/A	+11.63%
2009	N/A	-23.14%
2008	N/A	+8.61%
2007	N/A	-22.44%
2006	N/A	+22.97%
2005	N/A	+13.17%
2004	N/A	+34.21%
2003	N/A	+56.27%
2002	N/A	+16.49%
2001	N/A	+72.14%
2000	N/A	-15.69%
1999	N/A	-12.81%

SYRE vs GBCI Drawdown Comparison

The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.

The maximum drawdown for GBCI was -63.19%, occurring on Oct 3, 2011. Recovery took 1204 trading sessions.

The current SYRE drawdown is -76.62%. The current GBCI drawdown is -17.61%.

Rank	SYRE	GBCI
#1	-99.11% Apr 8, 2016 - Jun 21, 2023	-63.19% Sep 18, 2008 - Jul 2, 2013
#2	N/A	-56.50% Mar 12, 2021 - May 11, 2023
#3	N/A	-42.08% Dec 24, 2019 - Jun 5, 2020
#4	N/A	-40.49% Feb 23, 2007 - Sep 16, 2008
#5	N/A	-38.37% Nov 1, 1999 - May 10, 2001
#6	N/A	-33.40% Jun 5, 2020 - Dec 14, 2020
#7	N/A	-25.19% Dec 23, 2013 - Jun 10, 2015
#8	N/A	-24.51% Dec 1, 2004 - Jul 22, 2005
#9	N/A	-23.82% Nov 6, 2015 - Aug 18, 2016
#10	N/A	-20.86% Nov 30, 2018 - Dec 17, 2019
#11	N/A	-18.58% Jun 23, 2015 - Nov 6, 2015
#12	N/A	-18.40% Jun 27, 2002 - Jan 9, 2003
#13	N/A	-16.16% Mar 1, 2017 - Sep 27, 2017
#14	N/A	-15.35% Sep 11, 2018 - Nov 16, 2018
#15	N/A	-14.88% Sep 7, 2001 - Dec 4, 2001

Correlation

Correlation between SYRE and GBCI is -0.34 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.34

-101